Oral nutrition supplements and between-meal snacks for nutrition therapy in patients with COPD identified as at nutritional risk: a randomised feasibility trial

dc.contributorHáskóli Íslandsen_US
dc.contributorUniversity of Icelanden_US
dc.contributor.authorIngadottir, Arora Ros
dc.contributor.authorBeck, Anne Marie
dc.contributor.authorBaldwin, Christine
dc.contributor.authorWeekes, Christine Elizabeth
dc.contributor.authorGeirsdottir, Olof
dc.contributor.authorRamel, Alfons
dc.contributor.authorGislason, Thorarinn
dc.contributor.authorGunnarsdottir, Ingibjorg
dc.contributor.departmentMatvæla- og næringarfræðideild (HÍ)en_US
dc.contributor.departmentFaculty of Food Science and Nutrition (UI)en_US
dc.contributor.departmentLæknadeild (HÍ)en_US
dc.contributor.departmentFaculty of Medicine (UI)en_US
dc.contributor.schoolHeilbrigðisvísindasvið (HÍ)en_US
dc.contributor.schoolSchool of Health Sciences (UI)en_US
dc.date.accessioned2020-08-06T13:40:02Z
dc.date.available2020-08-06T13:40:02Z
dc.date.issued2019-01
dc.descriptionPublisher's version (útgefin grein)en_US
dc.description.abstractIntroduction Intervention studies have mainly used oral nutritional supplements (ONS) for the management of patients with chronic obstructive pulmonary disease (COPD) identified as at nutritional risk. In this 12-month randomised feasibility trial, we assessed the (1) feasibility of the recruitment, retention and provision of two interventions: ONS and between-meal snacks (snacks) and (2) the potential impact of the provision of snacks and ONS on body weight and quality of life in patients with COPD. Methods Hospitalised patients with COPD, at nutritional risk, were randomised to ONS (n=19) or snacks (n=15) providing 600 kcal and 22 g protein a day in addition to regular daily diet. The intervention started in hospital and was continued for 12 months after discharge from the hospital. Results Study recruitment rate was n=34 (45%) and retention rate at 12 months was similar for both groups: n=13 (68%) in the ONS group and n=10 (67%) in the Snacks group. Both groups gained weight from baseline to 12 months (2.3±4.6 kg (p=0.060) in the ONS group and 4.4±6.4 kg (p=0.030) in the Snacks group). The St George’s Respiratory Questionnaire total score improved from baseline to 12 months in both groups (score 3.9±11.0 (p=0.176) in the ONS group and score 8.9±14.1 (p=0.041) in the Snacks group). Discussion In patients with COPD who are at nutritional risk snacks are at least as feasible and effective as ONS, however, adequately powered trials that take account of the difficulties in recruiting this patient group are required to confirm this effect. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0en_US
dc.description.sponsorshipThis paper presents independent research that was supported by the Icelandic Research Fund of the Icelandic Centre for Research (141216-051), the Eimskip University Fund and the Landspitali University Hospital Research Fund. Oral nutritional supplements were partly funded by Nutricia (Icepharma) and between meals by MS Iceland Dairies (Mjólkursamsalan).en_US
dc.description.versionPeer Revieweden_US
dc.format.extente000349en_US
dc.identifier.citationIngadottir AR, Beck AM, Baldwin C, et al. Oral nutrition supplements and between-meal snacks for nutrition therapy in patients with COPD identified as at nutritional risk: a randomised feasibility trial. BMJ Open Resp Res 2019;6:e000349. doi:10.1136/ bmjresp-2018-000349en_US
dc.identifier.doi10.1136/bmjresp-2018-000349
dc.identifier.issn2052-4439
dc.identifier.journalBMJ Open Respiratory Researchen_US
dc.identifier.urihttps://hdl.handle.net/20.500.11815/1927
dc.language.isoenen_US
dc.publisherBMJen_US
dc.relation.ispartofseriesBMJ Open Respiratory Research;6(1)
dc.relation.urlhttps://syndication.highwire.org/content/doi/10.1136/bmjresp-2018-000349en_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectMataræðien_US
dc.subjectHollusta mataren_US
dc.subjectLungnasjúkdómaren_US
dc.titleOral nutrition supplements and between-meal snacks for nutrition therapy in patients with COPD identified as at nutritional risk: a randomised feasibility trialen_US
dc.typeinfo:eu-repo/semantics/articleen_US
dcterms.licenseThis is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0en_US

Skrár

Original bundle

Niðurstöður 1 - 1 af 1
Hleð...
Thumbnail Image
Nafn:
Oral nutrition supplements and between-meal snacks for nutrition therapy in patients with COPD identified as at nutritional risk- a randomised feasibility trial.pdf
Stærð:
885.7 KB
Snið:
Adobe Portable Document Format
Description:
Publisher's version (útgefin grein)

Undirflokkur